OTHER GROUP COMPANIES
market

USFDA conducts inspection of Lupins Mandideep Unit-1

Issues eight observation under Form 483

November 24, 2022 6:53 IST | capital market
Lupin announced that the U.S. FDA inspected Lupins Mandideep Unit-1 facility from 14 November 2022 to 23 November 2022. The inspection of the facility closed with issuance of a Form 483 with eight observations each for the Drug Product facility and API facility at the site. Powered by Capital Market - Live News

Invest wise with Expert advice

FEATURED ARTICLE

BLOGS

Open Demat Account

Invest wise with Expert advice

By continuing, I accept the Terms & Conditions and agree to receive updates on Whatsapp